[eGongsi Notice Catches Attention] KOSDAQ - 7 Days

[Asia Economy Reporter Lee Seon-ae]

▲Gwanglim=Entered into a stock collateral provision contract accompanying a change in the largest shareholder; all 14,438,534 shares (18.52%) held by Kallas Holdings were pledged as collateral to Daol Savings Bank for 13 billion KRW

▲Ilsin Bio=Qualified opinion due to limitation of audit scope, grounds for delisting; objections can be filed within 15 days; if no objections are filed, delisting procedures will proceed

▲Sports Seoul=KOSDAQ Market Committee decided on delisting; organized trading until the 19th; delisting date is the 20th

▲SMAC=Receipt of objection to delisting and granted improvement period

▲Huons Blossom=Huons Global, Huno Lab, and Mr. Yoon Yeon-sang acquired 5.2 million shares of Hubena for 28.512 billion KRW, corresponding to 68.86% of total assets and 75.32% of equity capital

▲Sangsangin Industry=Entered into a supply contract worth 7.2 billion KRW with largest shareholder Sangsangin Ship Machinery for a 40T Level Luffing Crane (LLC)

▲HK Innoen=Announced Phase 1 clinical trial results evaluating the pharmacokinetic and pharmacodynamic characteristics, safety, and tolerability of Tegoprazan

▲Namuga=Exercised 2 billion KRW worth of the 4th anonymous, unsecured, privately placed non-separable bonds with warrants

▲BDI=Grounds for delisting due to auditor’s refusal of audit opinion

▲Chorokbam Company=Conversion request for 4,012,878 convertible preferred shares and 5,193,131 common shares

▲Clio=Completed sale and purchase contract for land and building located at 656-461, Seongsu-dong 1-ga, Seongdong-gu, Seoul for 30 billion KRW

This content was produced with the assistance of AI translation services.